Titre A Comprehensive and Observational Myeloproliferative Neoplasms (MPN) Registry in the Province of Quebec
Protocole ID Registre des NMP (CINC424BCA04T)
ClinicalTrials.gov ID
Type(s) de cancer NMP : Vaquez , Thrombocythémie essentielle, Métaplasie myéloide
Phase Autres
Institution CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
   PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
      5415 boul. de l'Assomption, Montréal, QC, H1T2M4
Ville Montréal
Investigateur(trice) principal(e) Dr Lambert Busque
Coordonnateur(trice) Michel-Olivier Gratton
514-252-3400 poste 2397
Statut Actif en recrutement
Critètes d'éligibilité All patients who meet the following inclusion criteria may be enrolled in the MPN Registry:
  • Have a diagnosis of PV, ET, or MF as defined by the World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms [7];
  • Are 18 years of age or older;
  • Are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
Critètes d'exclusion Patients who meet any of the following criteria will be excluded from participation:
  • Life expectancy of less than 3 months for a condition not related to MPN;
  • Patients suffering of CML.